Dr. Stephen Ellis summarizes the discussions surrounding bioabsorbable scaffolding or stents: why they were hypothesized, the results of the trials; and where we are now.
Dr. Steve Nissen discusses the results of three important late breaking trials looking at the impact of three drugs on cardiovascular endpoints: the CANTOS trial (Canakinumab); the REVEAL study…
Dr. Stephen Ellis discusses the results of recent trials at ACC related to Instantaneous Wave-Free Ration (iFR) and how the results impact practice in the cath lab.
Dr. Stephen Ellis discusses the results of recent bioresorbable stent trials including the ABSORB III trial and what the results mean for clinical practice.